Hallmark Capital Management Inc Eli Lilly & CO Transaction History

Hallmark Capital Management Inc

$1.32 Billion
Q3 2024

A detailed history of Hallmark Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Hallmark Capital Management Inc holds 2,260 shares of LLY stock, worth $1.8 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

2,260

Previous 1,788 26.4%

Holding current value

$1.8 Million

Previous $1.62 Million 23.73%

% of portfolio

0.15%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$772.14 - $960.02 $364,450 - $453,129	472 Added 26.4%	2,260 $2 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $35,518 - $44,542	49 Added 2.82%	1,788 $1.62 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $315,050 - $421,492	532 Added 44.08%	1,739 $1.35 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $38,338 - $45,196	-73 Reduced 5.7%	1,207 $703,000
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $7,389 - $10,188	17 Added 1.35%	1,280 $687,000
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $2,104 - $2,813	-6 Reduced 0.47%	1,263 $592,000
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $16,152 - $18,970	-52 Reduced 3.94%	1,269 $435,000
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $172,350 - $200,823	536 Added 68.28%	1,321 $483,000
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $17,601 - $21,874	-75 Reduced 8.72%	785 $225,000
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $193,371 - $239,974	860 New	860 $238,000
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $205,286 - $254,265	-1,920 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $1.71 Million - $2 Million	-15,437 Reduced 88.94%	1,920 $213,000
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $103,518 - $121,848	-930 Reduced 5.09%	17,357 $2.25 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $197,503 - $221,263	-1,865 Reduced 9.25%	18,287 $2.12 Million
Q3 2018 Oct 26, 2018	SELL	$85.86 - $107.31 $222,720 - $278,362	-2,594 Reduced 11.4%	20,152 $2.16 Million
Q2 2018 Aug 02, 2018	BUY	$75.7 - $86.88 $7,494 - $8,601	99 Added 0.44%	22,746 $1.94 Million
Q1 2018 Apr 27, 2018	BUY	$74.21 - $87.6 $192,203 - $226,883	2,590 Added 12.91%	22,647 $1.75 Million
Q4 2017 Jan 24, 2018	BUY	$81.94 - $87.89 $34,988 - $37,529	427 Added 2.18%	20,057 $1.69 Million
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $1.51 Million - $1.68 Million	19,630	19,630 $1.68 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hallmark Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hallmark Capital Management Inc with notifications on news.

Account

Hallmark Capital Management Inc Eli Lilly & CO Transaction History